全文获取类型
收费全文 | 45972篇 |
免费 | 2318篇 |
国内免费 | 374篇 |
学科分类
医药卫生 | 48664篇 |
出版年
2023年 | 307篇 |
2022年 | 322篇 |
2021年 | 1491篇 |
2020年 | 814篇 |
2019年 | 1153篇 |
2018年 | 1598篇 |
2017年 | 1047篇 |
2016年 | 1143篇 |
2015年 | 1334篇 |
2014年 | 1844篇 |
2013年 | 2394篇 |
2012年 | 3718篇 |
2011年 | 3689篇 |
2010年 | 2060篇 |
2009年 | 1792篇 |
2008年 | 3104篇 |
2007年 | 3220篇 |
2006年 | 3011篇 |
2005年 | 2977篇 |
2004年 | 2708篇 |
2003年 | 2402篇 |
2002年 | 2132篇 |
2001年 | 324篇 |
2000年 | 239篇 |
1999年 | 337篇 |
1998年 | 383篇 |
1997年 | 338篇 |
1996年 | 299篇 |
1995年 | 294篇 |
1994年 | 232篇 |
1993年 | 177篇 |
1992年 | 161篇 |
1991年 | 128篇 |
1990年 | 129篇 |
1989年 | 106篇 |
1988年 | 96篇 |
1987年 | 82篇 |
1986年 | 86篇 |
1985年 | 92篇 |
1984年 | 84篇 |
1983年 | 76篇 |
1982年 | 94篇 |
1981年 | 64篇 |
1980年 | 69篇 |
1979年 | 47篇 |
1978年 | 53篇 |
1977年 | 41篇 |
1976年 | 37篇 |
1975年 | 33篇 |
1974年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
1.
2.
3.
4.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
5.
6.
7.
Susanna Zanutto Chiara Maura Ciniselli Antonino Belfiore Mara Lecchi Enzo Masci Gabriele Delconte Massimo Primignani Giulia Tosetti Marco Dal Fante Linda Fazzini Aldo Airoldi Marcello Vangeli Francesca Turpini Giovanni Giuseppe Rubis Passoni Paolo Viaggi Monica Arena Roberta Ilaria Olimpia Motta Anna Maria Cantù Cristiano Crosta Giuseppe De Roberto Francesca Iannuzzi Andrea Cassinotti Valentina Dall'Olio Laura Tizzoni Gabriella Sozzi Emanuele Meroni Luigi Bisanti Marco Alessandro Pierotti Paolo Verderio Manuela Gariboldi 《International journal of cancer. Journal international du cancer》2020,146(4):1164-1173
Colorectal cancer (CRC) screening programs help diagnose cancer precursors and early cancers and help reduce CRC mortality. However, currently recommended tests, the fecal immunochemical test (FIT) and colonoscopy, have low uptake. There is therefore a pressing need for screening strategies that are minimally invasive and consequently more acceptable to patients, most likely blood based, to increase early CRC identification. MicroRNAs (miRNAs) released from cancer cells are detectable in plasma in a remarkably stable form, making them ideal cancer biomarkers. Using plasma samples from FIT-positive (FIT+) subjects in an Italian CRC screening program, we aimed to identify plasma circulating miRNAs that detect early CRC. miRNAs were initially investigated by quantitative real-time PCR in plasma from 60 FIT+ subjects undergoing colonoscopy at Fondazione IRCCS Istituto Nazionale dei Tumori, then tested on an internal validation cohort (IVC, 201 cases) and finally in a large multicenter prospective series (external validation cohort [EVC], 1121 cases). For each endoscopic lesion (low-grade adenoma [LgA], high-grade adenoma [HgA], cancer lesion [CL]), specific signatures were identified in the IVC and confirmed on the EVC. A two-miRNA-based signature for CL and six-miRNA signatures for LgA and HgA were selected. In a multivariate analysis including sex and age at blood collection, the areas under the receiver operating characteristic curve (95% confidence interval) of the signatures were 0.644 (0.607–0.682), 0.670 (0.626–0.714) and 0.682 (0.580–0.785) for LgA, HgA and CL, respectively. A miRNA-based test could be introduced into the FIT+ workflow of CRC screening programs so as to schedule colonoscopies only for subjects likely to benefit most. 相似文献
8.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features 下载免费PDF全文
9.
La Rosa Mauricio Omere Chasey Redfern Tiffany Abdelwahab Mahmoud Spencer Nicholas Villarreal Josephine Olson Gayle Saade George R. Saad Antonio F. 《Archives of gynecology and obstetrics》2020,301(1):69-73
Archives of Gynecology and Obstetrics - The objective of this study was to determine if high-dose antibiotic prophylaxis with cefazolin decreases the risk of surgical site infection (SSI) after a... 相似文献